NDC 0003-3756

OPDIVO

Nivolumab

OPDIVO is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Nivolumab.

• Product ID: 0003-3756_546afcdf-954f-4877-9066-b7c81381f0bb
• NDC: 0003-3756
• Product Type: Human Prescription Drug
• Proprietary Name: OPDIVO
• Generic Name: Nivolumab
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-08-30
• Marketing Category: BLA /
• Application Number: BLA125554
• Labeler Name: E.R. Squibb & Sons, L.L.C.
• Substance Name: NIVOLUMAB
• Active Ingredient Strength: 10 mg/mL
• Pharm Classes: Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0003-3756-14

1 VIAL, SINGLE-DOSE in 1 CARTON (0003-3756-14) > 12 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2021-08-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "OPDIVO" or generic name "Nivolumab"

NDC	Brand Name	Generic Name
0003-3734	OPDIVO	nivolumab
0003-3756	OPDIVO	nivolumab
0003-3772	OPDIVO	nivolumab
0003-3774	OPDIVO	OPDIVO